Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Montironi

Showing results (51-60 of 801) with videos related to

Pageof 81
Sort By:
Analytical and Quantitative Cytology and Histology|July 29, 2003
TP53 in urologic tumorsFerran Algaba, Isabel Trias, Alfredo Santinelli, et al.
European Urology|November 5, 2018
Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell CarcinomaMatteo Santoni, Rodolfo Montironi, Nicola Battelli, et al.
Advances in Anatomic Pathology|April 12, 2017
Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic VariancesGladell P Paner, Rodolfo Montironi, Mahul B Amin
Expert Review of Molecular Diagnostics|September 3, 2020
Potential biomarkers and risk assessment models to enhance the tumor-node-metastasis (TNM) staging classification of urologic cancersCaitlin M Darrell, Rodolfo Montironi, Gladell P Paner
European Urology Focus|May 17, 2021
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and ObservationsRodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, et al.
The American Journal of Surgical Pathology|October 13, 2011
Cervical-type squamous metaplasia and myoepithelial cell differentiation in stromal tumor of the prostateRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Role of histopathology and molecular markers in the active surveillance of prostate cancerRodolfo Montironi, Lars Egevad, Anders Bjartell, et al.
European Urology|August 11, 2018
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2?Rodolfo Montironi, Liang Cheng, Alessia Cimadamore, et al.
European Urology|February 8, 2017
From Gleason Grading System and High-grade Tertiary Patterns to Grade Groups and Integrated Quantitative Gleason ScoreRodolfo Montironi, Liang Cheng, Marina Scarpelli, et al.
European Urology|September 26, 2025
Re: Lucia L. Rijstenberg, Hridya Harikumara, Esther I. Verhoef, et al. Identification of Intraductal-to-Invasive Spatial Transitions in Prostate Cancer: Proposal for a New Unifying Model on Intraductal Carcinogenesis. Histopathology 2025;86:1091-100Rodolfo Montironi, Alessia Cimadamore, Antonio Lopez-Beltran, et al.
Pageof 81

Showing results (51-60 of 801) with videos related to

Sort By:
Pageof 81
Analytical and Quantitative Cytology and Histology|July 29, 2003
TP53 in urologic tumorsFerran Algaba, Isabel Trias, Alfredo Santinelli, et al.
European Urology|November 5, 2018
Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell CarcinomaMatteo Santoni, Rodolfo Montironi, Nicola Battelli, et al.
Advances in Anatomic Pathology|April 12, 2017
Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic VariancesGladell P Paner, Rodolfo Montironi, Mahul B Amin
Expert Review of Molecular Diagnostics|September 3, 2020
Potential biomarkers and risk assessment models to enhance the tumor-node-metastasis (TNM) staging classification of urologic cancersCaitlin M Darrell, Rodolfo Montironi, Gladell P Paner
European Urology Focus|May 17, 2021
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and ObservationsRodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, et al.
The American Journal of Surgical Pathology|October 13, 2011
Cervical-type squamous metaplasia and myoepithelial cell differentiation in stromal tumor of the prostateRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Role of histopathology and molecular markers in the active surveillance of prostate cancerRodolfo Montironi, Lars Egevad, Anders Bjartell, et al.
European Urology|August 11, 2018
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2?Rodolfo Montironi, Liang Cheng, Alessia Cimadamore, et al.
European Urology|February 8, 2017
From Gleason Grading System and High-grade Tertiary Patterns to Grade Groups and Integrated Quantitative Gleason ScoreRodolfo Montironi, Liang Cheng, Marina Scarpelli, et al.
European Urology|September 26, 2025
Re: Lucia L. Rijstenberg, Hridya Harikumara, Esther I. Verhoef, et al. Identification of Intraductal-to-Invasive Spatial Transitions in Prostate Cancer: Proposal for a New Unifying Model on Intraductal Carcinogenesis. Histopathology 2025;86:1091-100Rodolfo Montironi, Alessia Cimadamore, Antonio Lopez-Beltran, et al.
Pageof 81